OBJECTIVE: The aim of the study was to evaluate whether vitamin D [25-(OH) D3] status affects serum IGFI concentrations in healthy subjects. DESIGN AND PATIENTS: Two hundred and forty-one consecutive healthy subjects were included in the present study. MEASUREMENTS: Serum IGF-I and 25-(OH) D3 concentrations. RESULTS: As expected, serum IGF-I concentrations progressively decreased with age (r=-0.55, p<0.0001); on the contrary, gender was not related to serum IGF-I levels. A positive relationship was identified between serum 25-(OH) D3 and IGF-I concentrations (r=0.33, p<0.0001); the 25-(OH) D3-dependent changes of serum IGF-I concentrations were observed also when subjects were divided on the basis of vitamin D deficiency; in fact, those with severe 25-(OH) D3 deficiency (<20 ng/ml) had lower (185 ± 83 μg/l) IGF-I values than those with mild-to absent 25-(OH) D3 deficit (225 ± 83 μg/l, p=0.0004). CONCLUSIONS: 25-(OH) D3 status may contribute to determine serum IGF-I levels in healthy population.
OBJECTIVE: The aim of the study was to evaluate whether vitamin D [25-(OH) D3] status affects serum IGFI concentrations in healthy subjects. DESIGN AND PATIENTS: Two hundred and forty-one consecutive healthy subjects were included in the present study. MEASUREMENTS: Serum IGF-I and 25-(OH) D3 concentrations. RESULTS: As expected, serum IGF-I concentrations progressively decreased with age (r=-0.55, p<0.0001); on the contrary, gender was not related to serum IGF-I levels. A positive relationship was identified between serum 25-(OH) D3 and IGF-I concentrations (r=0.33, p<0.0001); the 25-(OH) D3-dependent changes of serum IGF-I concentrations were observed also when subjects were divided on the basis of vitamin D deficiency; in fact, those with severe 25-(OH) D3 deficiency (<20 ng/ml) had lower (185 ± 83 μg/l) IGF-I values than those with mild-to absent 25-(OH) D3 deficit (225 ± 83 μg/l, p=0.0004). CONCLUSIONS: 25-(OH) D3 status may contribute to determine serum IGF-I levels in healthy population.
Authors: G Aimaretti; M Boschetti; G Corneli; V Gasco; D Valle; M Borsotti; A Rossi; A Barreca; L Fazzuoli; D Ferone; E Ghigo; F Minuto Journal: J Endocrinol Invest Date: 2008-05 Impact factor: 4.256
Authors: M Fernández-Cancio; L Audi; A Carrascosa; N Toran; P Andaluz; C Esteban; M L Granada Journal: Growth Horm IGF Res Date: 2008-12-03 Impact factor: 2.372
Authors: Jay H Fowke; Charles E Matthews; Herbert Yu; Qiuyin Cai; Sarah Cohen; Maciej S Buchowski; Wei Zheng; William J Blot Journal: Endocr Relat Cancer Date: 2010-01-29 Impact factor: 5.678
Authors: José Manuel Gómez; Francisco Javier Maravall; Núria Gómez; Miguel Angel Navarro; Roser Casamitjana; Juan Soler Journal: Growth Horm IGF Res Date: 2004-04 Impact factor: 2.372
Authors: Christian Trummer; Verena Schwetz; Marlene Pandis; Martin R Grübler; Nicolas Verheyen; Martin Gaksch; Armin Zittermann; Winfried März; Felix Aberer; Angelika Lang; Claudia Friedl; Andreas Tomaschitz; Barbara Obermayer-Pietsch; Thomas R Pieber; Stefan Pilz; Gerlies Treiber Journal: Nutrients Date: 2017-06-17 Impact factor: 5.717
Authors: Fayth L Miles; Phyllis J Goodman; Catherine Tangen; Kathleen C Torkko; Jeannette M Schenk; Xiaoling Song; Michael Pollak; Ian M Thompson; Marian L Neuhouser Journal: Nutrients Date: 2017-04-12 Impact factor: 5.717
Authors: Monika Bilic; Huma Qamar; Akpevwe Onoyovwi; Jill Korsiak; Eszter Papp; Abdullah Al Mahmud; Rosanna Weksberg; Alison D Gernand; Jennifer Harrington; Daniel E Roth Journal: Endocr Connect Date: 2019-06 Impact factor: 3.335